Following Public Fury, Jim Cramer-Trained CEO Who Raised Price Of Drug By 5000%, Agrees To Lower The Price | Zero Hedge:
"Not surprisingly, following the biggest plunge in biotech stocks in 2015 - many have speculated that the real goal of Shkreli's actions was to profit by shorting the biotech sector ahead of the selling which his action would have unleashed "
'via Blog this'
No comments:
Post a Comment